Hall said the “headline” achievements in 2025 included “two Medicare coverage decisions.” Personalis reported it received Medicare coverage for breast cancer surveillance in the fourth quarter with what it characterized as favorable pricing, and more recently received coverage for lung cancer surveillance. Hall emphasized that both reimbursement frameworks cover ongoing surveillance, allowing tests to be used at multiple time points over a patient’s journey.For 2026, management set initial annual clinical v ...